Cargando…

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs). Drug interaction databases are useful for identifying pDDIs to support safer medication use. Objective: To compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hecker, Michael, Frahm, Niklas, Bachmann, Paula, Debus, Jane Louisa, Haker, Marie-Celine, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Baldt, Julia, Streckenbach, Barbara, Heidler, Felicita, Zettl, Uwe Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416235/ https://www.ncbi.nlm.nih.gov/pubmed/36034780 http://dx.doi.org/10.3389/fphar.2022.946351

Ejemplares similares

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis
por: Langhorst, Silvan Elias, et al.
Publicado: (2022)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
por: Frahm, Niklas, et al.
Publicado: (2019)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

Patients’ Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions
por: Justad, Hanna, et al.
Publicado: (2021)

Potential drug-drug interactions of antiretrovirals and antimicrobials detected by three databases
por: Vivithanaporn, Pornpun, et al.
Publicado: (2021)

Drug–drug interaction database for safe prescribing of systemic antifungal agents
por: Niazi-Ali, Saarah, et al.
Publicado: (2021)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database
por: Hachad, Houda, et al.
Publicado: (2010)

Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Predicting Drug-Target Interactions Using Drug-Drug Interactions
por: Kim, Shinhyuk, et al.
Publicado: (2013)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases
por: Suriyapakorn, Bovornpat, et al.
Publicado: (2019)

The curse and blessing of abundance—the evolution of drug interaction databases and their impact on drug network analysis
por: Udrescu, Mihai, et al.
Publicado: (2023)

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database
por: Magro, Lara, et al.
Publicado: (2021)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

Drug-drug interactions in the ICU
por: Ray, S, et al.
Publicado: (2009)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

The drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development
por: Kunz, Meik, et al.
Publicado: (2016)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

Comparing Potential Drug–Drug Interactions in Companion Animal Medications Using Two Electronic Databases
por: Boonyarattanasoonthorn, Tussapon, et al.
Publicado: (2021)

FooDrugs: a comprehensive food–drug interactions database with text documents and transcriptional data
por: Lacruz-Pleguezuelos, Blanca, et al.
Publicado: (2023)

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
por: Trivedi, Ashit, et al.
Publicado: (2021)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Drug Interactions
por: Dollery, C.T., et al.
Publicado: (1980)

Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction
por: Gomez Lumbreras, Ainhoa, et al.
Publicado: (2022)

Understanding and preventing drug–drug and drug–gene interactions
por: Tannenbaum, Cara, et al.
Publicado: (2014)

Renal drug transporters and their significance in drug–drug interactions
por: Yin, Jia, et al.
Publicado: (2016)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
por: Vilar, Santiago, et al.
Publicado: (2013)

Leveraging genetic interactions for adverse drug-drug interaction prediction
por: Qian, Sheng, et al.
Publicado: (2019)

Drug-Drug Interaction Pattern Recognition
por: Duan, John Z.
Publicado: (2012)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ard356jk8j01a0cms2qp14acv